Evidence map›Paper›PMID 34440867›Full record

ArticleCells2021

High Glucose and Advanced Glycation End Products Induce CD147-Mediated MMP Activity in Human Adipocytes.

Abeer M Mahmoud, Mohamed M Ali

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Receptor for the Advanced Glycation End Products (International journal of molecular sciences · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Abeer M MahmoudDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0002-0295-6706
Mohamed M AliDepartment of Physical Therapy, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0001-8085-7132
University of Illinois Chicago · US

Funding

Shedding of Endothelial Glycocalyx in Morbidly Obese PatientsR00HL140049 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MOHAMED, ABEER M · 2019 to 2021
$889k
DNA Methylation and Vascular Function in Obesity: Role of Exercise and Weight LossK99HL140049 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MOHAMED, ABEER M · 2018 to 2019
$213k
NHLBI NIH HHS R00 HL140049NIH HHS K99HL140049
6 · The paper itself

Abstract

Basigin (CD147) is a transmembrane glycoprotein that regulates several physiological processes, including the production and activity of matrix metalloproteinases (MMPs). The activity of CD147 depends mainly on its glycosylation, which varies among pathophysiological conditions. However, it is unknown whether CD147 activity or its function in MMP regulation are affected by the diabetic environment, which is characterized by high glucose (HG) levels and an excess of glycation end products (AGEs). In this study, we investigated the effect of HG and AGEs on CD147 expression in human adipocytes. We also examined the mediating role of nuclear factor kappa B (NFκB) and receptor of AGE (RAGE) to this effect. Our findings show that carboxymethyl lysine and HG increased CD147 expression and glycosylation, which was accompanied by increases in MMP2 and MMP9 expression and activity, as well as upregulations of the

Indexed as

AdipocytesBasiginCells, CulturedGene SilencingGlucoseGlycation End Products, AdvancedGlycosylationHumansMatrix MetalloproteinasesN-AcetylglucosaminyltransferasesNF-kappa BReceptor for Advanced Glycation End ProductsBasiginBSG protein, humanGlucoseGlycation End Products, AdvancedMatrix MetalloproteinasesMgat5 protein, humanN-AcetylglucosaminyltransferasesNF-kappa BReceptor for Advanced Glycation End Productsadipocytesadvanced glycation end-productsCD147diabetesglycosylationmatrix metalloproteinases

Identifiers

PMID34440867
PMCPMC8392673
OpenAlexW3194021891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.